Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
14 07 2020
Historique:
received: 27 02 2020
accepted: 31 05 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 20 5 2021
Statut: ppublish

Résumé

The role of glycoprotein VI (GPVI) in platelets was investigated in 3 families bearing an insertion within the GP6 gene that introduces a premature stop codon prior to the transmembrane domain, leading to expression of a truncated protein in the cytoplasm devoid of the transmembrane region. Western blotting and flow cytometry of GP6hom (homozygous) platelets confirmed loss of the full protein. The level of the Fc receptor γ-chain, which associates with GPVI in the membrane, was partially reduced, but expression of other receptors and signaling proteins was not altered. Spreading of platelets on collagen and von Willebrand factor (which supports partial spreading) was abolished in GP6hom platelets, and spreading on uncoated glass was reduced. Anticoagulated whole blood flowed over immobilized collagen or a mixture of von Willebrand factor, laminin, and rhodocytin (noncollagen surface) generated stable platelet aggregates that express phosphatidylserine (PS). Both responses were blocked on the 2 surfaces in GP6hom individuals, but adhesion was not altered. Thrombin generation was partially reduced in GP6hom blood. The frequency of the GP6het (heterozygous) variant in a representative sample of the Chilean population (1212 donors) is 2.9%, indicating that there are ∼4000 GP6hom individuals in Chile. These results demonstrate that GPVI supports aggregation and PS exposure under flow on collagen and noncollagen surfaces, but not adhesion. The retention of adhesion may contribute to the mild bleeding diathesis of GP6hom patients and account for why so few of the estimated 4000 GP6hom individuals in Chile have been identified.

Identifiants

pubmed: 32603422
pii: S2473-9529(20)31623-2
doi: 10.1182/bloodadvances.2020001761
pmc: PMC7362345
doi:

Substances chimiques

Platelet Membrane Glycoproteins 0
platelet membrane glycoprotein VI 0
von Willebrand Factor 0
Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2953-2961

Subventions

Organisme : British Heart Foundation
ID : CH/03/003/15571
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/18/30563
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH03/003
Pays : United Kingdom
Organisme : British Heart Foundation
ID : AA/18/2/34218
Pays : United Kingdom

Informations de copyright

© 2020 by The American Society of Hematology.

Références

J Thromb Haemost. 2013 Sep;11(9):1751-9
pubmed: 23815599
J Biol Chem. 2012 Dec 28;287(53):44694-702
pubmed: 23132859
Blood. 2004 Feb 15;103(4):1333-41
pubmed: 14563646
Blood. 1999 Sep 1;94(5):1648-56
pubmed: 10477689
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1727-33
pubmed: 15231520
Curr Opin Hematol. 1998 Sep;5(5):314-20
pubmed: 9776209
J Clin Invest. 2019 Jan 2;129(1):12-23
pubmed: 30601137
Blood. 2015 Jul 30;126(5):683-91
pubmed: 25977585
Cell Mol Life Sci. 2012 Oct;69(20):3481-92
pubmed: 22669259
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):249-53
pubmed: 13679651
Blood. 2001 Jun 15;97(12):3836-45
pubmed: 11389024
Haematologica. 2018 May;103(5):898-907
pubmed: 29472360
Haematologica. 2019 Jun;104(6):1256-1267
pubmed: 30545925
Nat Commun. 2014 Jul 16;5:4257
pubmed: 25027852
Platelets. 2021 Jan 2;32(1):54-58
pubmed: 32321340
Blood. 2005 Aug 15;106(4):1268-77
pubmed: 15886326
Physiol Rev. 2013 Jan;93(1):327-58
pubmed: 23303912
J Thromb Haemost. 2007 Jan;5(1):201-3
pubmed: 17010148
Biochem J. 2002 Nov 15;368(Pt 1):293-300
pubmed: 12117414
J Thromb Haemost. 2013 Jan;11(1):2-16
pubmed: 23106920
Circulation. 2002 Jul 9;106(2):266-72
pubmed: 12105169
Nat Methods. 2019 Dec;16(12):1226-1232
pubmed: 31570887
Cell Regul. 1991 Nov;2(11):905-13
pubmed: 1809397
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EMBO J. 2001 May 1;20(9):2120-30
pubmed: 11331578
Front Cardiovasc Med. 2019 Jul 30;6:99
pubmed: 31417909
Thromb Haemost. 2000 May;83(5):769-76
pubmed: 10823276
J Biol Chem. 1998 Jun 12;273(24):14827-37
pubmed: 9614084
Thromb Haemost. 2005 Apr;93(4):716-23
pubmed: 15841318
Blood. 2015 Sep 24;126(13):1601-8
pubmed: 26282541
Haematologica. 2007 Mar;92(3):357-65
pubmed: 17339185
Sci Rep. 2019 Jan 28;9(1):772
pubmed: 30692554
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):692-9
pubmed: 26848157
Blood. 2003 Sep 1;102(5):1701-7
pubmed: 12738669

Auteurs

Magdolna Nagy (M)

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Gina Perrella (G)

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Amanda Dalby (A)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom.

M Francisca Becerra (MF)

Laboratorio de Trombosis y Hemostasia, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Lourdes Garcia Quintanilla (L)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Jeremy A Pike (JA)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom.

Neil V Morgan (NV)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Elizabeth E Gardiner (EE)

ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia; and.

Johan W M Heemskerk (JWM)

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Lorena Azócar (L)

Departmento de Gastroenterología, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Juan Francisco Miquel (JF)

Departmento de Gastroenterología, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Diego Mezzano (D)

Laboratorio de Trombosis y Hemostasia, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Steve P Watson (SP)

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH